Journalism of Courage
Advertisement
Prabha Raghavan
Authors you can follow
More From Prabha Raghavan - Page 3
Explained: What will you have to pay for Serum Institute’s Covishield vaccine after May 1?Subscriber Only
April 21, 2021 15:40 IST
The announcement is a result of the Narendra Modi government’s decision to open up vaccinations against Covid-19 to those above the age of 18 years.
Tue, Apr 27, 2021
Don’t wash hands of vaccine, what about the poor: Opp states to CentreSubscriber Only
April 21, 2021 04:15 IST
While BJP state governments of Uttar Pradesh and Assam both announced free vaccines for all, other states said the Centre was washing its hands of the responsibility.
Wed, Apr 21, 2021
Before ramp-up, vaccine planning on the fly with only 2 options in basketSubscriber Only
April 21, 2021 04:12 IST
India has largely been reliant on a real-time supply of vaccines from essentially a duopoly of suppliers.
Thu, Apr 22, 2021
Explained: Why does India need Covid-19 vaccine ingredients from US?Subscriber Only
April 20, 2021 04:30 IST
The CEO of Serum Institute of India has urged President Joe Biden to lift the US embargo on export of vaccine raw materials. How important are these raw materials to vaccine manufacturers in India and other countries?
Fri, Apr 30, 2021
Vaccine makers had sought funding help, market access opens up revenue sourceSubscriber Only
April 20, 2021 04:11 IST
The change in rules would effectively enable the Health Ministry to make advance payments of Rs 3,000 crore to Serum Institute of India (SII) and Rs 1,500 crore to Bharat Biotech for procuring vaccines.
Tue, Apr 20, 2021
Shortage of vaccine raw materials, SII CEO to Biden: End export embargoSubscriber Only
April 17, 2021 04:59 IST
In a Twitter post, tagging the US President, Poonawalla said: “Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details.”
Tue, Apr 20, 2021
Dr Reddy’s: Sputnik V will start arriving in this quarterSubscriber Only
April 15, 2021 02:30 IST
The availability of the vaccine in India will, however, depend ultimately on factors such as the number of doses that the government wishes to procure, the price, and the capacity of the country's cold chain system to distribute the vaccine.
Thu, Apr 15, 2021
Door for global vaccines opens but pricing strategy could be key to entrySubscriber Only
April 14, 2021 04:03 IST
The NDA government is learnt to have negotiated the cost of Covishield — Serum Institute of India’s (SII) version of the AstraZeneca-University of Oxford vaccine -- to Rs 150 plus GST, or around $2.02, per dose.
Wed, Apr 14, 2021
Covid-19 second surge: Centre clears way for foreign vaccines, fast-tracks approvalSubscriber Only
April 14, 2021 02:00 IST
The Centre said that decision will facilitate quicker access to such foreign vaccines by India and would encourage imports including import of bulk drug material, optimal utilization of domestic fill, and finish capacity.
Wed, Apr 14, 2021
Sputnik V has got Indian regulatory approval, says Russia’s sovereign wealth fundSubscriber Only
April 13, 2021 01:24 IST
Announcement comes hours after an expert panel recommended emergency use authorisation for Covid-19 vaccine. India now has three vaccines to fight the coronavirus surge.
Tue, Apr 13, 2021
Panel clears Sputnik, could soon be India’s 3rd shot against Covid-19 surgeSubscriber Only
April 13, 2021 01:00 IST
Some experts feel the approval would also ease the pressure on Serum Institute of India (SII) and Bharat Biotech to rapidly scale up production of their vaccines – Covishield and Covaxin – amid the ongoing surge.
Tue, Apr 13, 2021
Explained: Reading the data on post-vaccination effects and deaths in IndiaSubscriber Only
April 10, 2021 01:18 IST
Since January 16 this year, 95.43 million doses of Covid-19 vaccines have been administered, with around 11.27 million people receiving both doses of either Covishield or Covaxin.
Tue, May 11, 2021
Top panel widens Covishield, Covaxin review to look for possible red flagsSubscriber Only
April 09, 2021 02:58 IST
Govt on alert following AstraZeneca vaccine being linked to rare blood clots.
Fri, Apr 09, 2021Other Covid-19 vaccines stuck over data, tests, raw material issuesSubscriber Only
April 08, 2021 04:30 IST
Over the last year, India has been building capabilities to manufacture large quantities of vaccines like Sputnik V, Covovax and the Janssen vaccine.
Thu, Apr 08, 2021
Decision on Sputnik V: Panel seeks additional data from Dr Reddy’sSubscriber Only
April 02, 2021 05:19 IST
Sources said the SEC also asked DRL to submit data on the vaccine’s stability.
Fri, Apr 02, 2021
Third dose of Covaxin gets nod for trials, six months after 2nd shotSubscriber Only
April 02, 2021 04:30 IST
Bharat Biotech is also to follow up these participants “at least for six months after the third dose,” according to minutes of the SEC’s meeting dated March 23.
Fri, Apr 02, 2021
Cabinet clears Rs 10,900-crore PLI scheme for food processingSubscriber Only
April 01, 2021 03:00 IST
Addressing reporters after the Cabinet meeting, Minister for Consumer Affairs, Food and Public Distribution Piyush Goyal said this PLI scheme will help raise the processed food sector’s share in India’s total exports basket.
Thu, Apr 01, 2021
Brazil regulator flags safety issues in Covaxin production, denies certificateSubscriber Only
April 01, 2021 02:20 IST
The move, which does not affect Bharat Biotech’s application for emergency use authorisation of the vaccine in Brazil, could potentially still delay its ability to supply doses of the Covid-19 vaccine to the country until the issue is resolved.
Thu, Apr 01, 2021
Explained: Why is Pakistan lifting its ban on Indian imports?Subscriber Only
March 31, 2021 15:06 IST
Why did Pakistan stop the imports of cotton and sugar from India, and why has it reversed its decision? What kind of trade relations have the two countries had?
Sat, Apr 03, 2021
Amid global curbs, CSIR-IICT, 3 cos to develop vaccine components locallySubscriber Only
March 30, 2021 01:44 IST
The agreement, which entails making vaccine adjuvants and other raw materials, comes at a time when countries like the US have restricted supplies of crucial components to make Covid-19 shots.
Tue, Mar 30, 2021
Covovax screening process to start in PuneSubscriber Only
March 27, 2021 08:44 IST
The company expects to launch Covovax by August following the bridging study in India. This study will be conducted using 1,600 participants in 19 sites across Delhi, UP, Maharashtra, Kerala, Punjab, Puducherry, Odisha, Karnataka and West Bengal.
Sat, Mar 27, 2021
Explained: Why has the interval between Covishield vaccine doses been raised to 8 weeks?Subscriber Only
March 23, 2021 03:30 IST
Covishield is Serum Institute of India’s version of AZD1222, the vaccine developed by AstraZeneca in collaboration with the University of Oxford.
Thu, May 27, 2021
No blood clot risk from Covishield & Covaxin: Top panelSubscriber Only
March 23, 2021 03:01 IST
These findings have been presented to the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) as well as GACVS, of which Dr Arora is also a member.
Tue, Mar 23, 2021
Explained: What latest efficacy data of Oxford-AstraZeneca Covid-19 vaccine meansSubscriber Only
March 22, 2021 17:33 IST
According to The University of Oxford and AstraZeneca, interim results from phase 3 clinical trial, the vaccine had an efficacy of 79 per cent against symptomatic Covid-19.
Wed, Mar 24, 2021
Explained: Covovax vaccine for Covid-19, and Serum Institute of India’s bridging studySubscriber Only
March 20, 2021 01:29 IST
Covovax is Serum Institute of India's version of NVX-CoV2373, the protein-based Covid-19 vaccine developed by Novavax, headquartered in USA.
Wed, Mar 24, 2021Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us